| scholarly article | Q13442814 |
| P50 | author | Steven C Moore | Q47712617 |
| Mary C Playdon | Q81394582 | ||
| Regina G. Ziegler | Q90946208 | ||
| Robert N. Hoover | Q118558329 | ||
| P2093 | author name string | Joshua N Sampson | |
| Charles E Matthews | |||
| Britton Trabert | |||
| P2860 | cites work | alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population | Q21136353 |
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Understanding the Warburg effect: the metabolic requirements of cell proliferation | Q24604760 | ||
| Fundamentals of cancer metabolism | Q26744062 | ||
| Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants | Q26749640 | ||
| Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status | Q27012792 | ||
| A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity. | Q27852958 | ||
| A Metabolomic Approach to Understanding the Metabolic Link between Obesity and Diabetes | Q28083355 | ||
| Hypothalamic mTOR signaling regulates food intake | Q28239714 | ||
| A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance | Q28240815 | ||
| Structure-based design and mechanisms of allosteric inhibitors for mitochondrial branched-chain α-ketoacid dehydrogenase kinase | Q28291558 | ||
| On the mechanisms of the formation of L-alloisoleucine and the 2-hydroxy-3-methylvaleric acid stereoisomers from L-isoleucine in maple syrup urine disease patients and in normal humans | Q28317249 | ||
| Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency | Q28362416 | ||
| Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change | Q28542592 | ||
| Biomarkers for type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach | Q28661494 | ||
| Metabolite profiles and the risk of developing diabetes | Q29615359 | ||
| Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms | Q29615455 | ||
| Minireview: 16alpha-hydroxylated metabolites of dehydroepiandrosterone and their biological significance. | Q34080787 | ||
| Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. | Q34087177 | ||
| Human metabolic correlates of body mass index | Q34218551 | ||
| DHEA metabolites activate estrogen receptors alpha and beta | Q34309799 | ||
| Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development | Q34315320 | ||
| Odds ratios for mediation analysis for a dichotomous outcome | Q34386374 | ||
| Body Fatness and Cancer--Viewpoint of the IARC Working Group. | Q34538369 | ||
| Sodium phenylbutyrate, a drug with known capacity to reduce endoplasmic reticulum stress, partially alleviates lipid-induced insulin resistance and beta-cell dysfunction in humans | Q34615491 | ||
| Brain insulin lowers circulating BCAA levels by inducing hepatic BCAA catabolism. | Q34624088 | ||
| Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer | Q35537836 | ||
| Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up | Q35677465 | ||
| Estrogen metabolism and risk of breast cancer in postmenopausal women. | Q35769029 | ||
| Steroid hormone measurements from different types of assays in relation to body mass index and breast cancer risk in postmenopausal women: Reanalysis of eighteen prospective studies | Q35852411 | ||
| Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes. | Q35919864 | ||
| Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk | Q36294958 | ||
| Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach | Q36560652 | ||
| Inborn errors of isoleucine degradation: a review | Q36584759 | ||
| Amino Acids Rather than Glucose Account for the Majority of Cell Mass in Proliferating Mammalian Cells | Q36614447 | ||
| Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up | Q36638994 | ||
| Metabolomics in epidemiology: sources of variability in metabolite measurements and implications | Q36741738 | ||
| Impact of Pre-analytic Blood Sample Collection Factors on Metabolomics | Q36918149 | ||
| A novel fasting blood test for insulin resistance and prediabetes. | Q36954280 | ||
| BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. | Q37028013 | ||
| Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women | Q37090766 | ||
| Prevalence and mutation analysis of short/branched chain acyl-CoA dehydrogenase deficiency (SBCADD) detected on newborn screening in Wisconsin | Q37220977 | ||
| Plasma metabolomic profiles in association with type 2 diabetes risk and prevalence in Chinese adults | Q37403973 | ||
| Rediscovery rate estimation for assessing the validation of significant findings in high-throughput studies | Q38254343 | ||
| Metabolomic biomarkers for obesity in humans: a short review. | Q38258525 | ||
| Epidemiologic studies of estrogen metabolism and breast cancer | Q38366037 | ||
| Adiposity and cancer risk: new mechanistic insights from epidemiology | Q38553013 | ||
| Metabolites Associated With Lean Mass and Adiposity in Older Black Men. | Q38774796 | ||
| Alloisoleucine differentiates the branched-chain aminoacidemia of Zucker and dietary obese rats | Q39179587 | ||
| Comparing metabolite profiles of habitual diet in serum and urine | Q39502852 | ||
| Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial | Q39558136 | ||
| Integrated Network Analysis Reveals an Association between Plasma Mannose Levels and Insulin Resistance | Q39654229 | ||
| Nutritional metabolomics and breast cancer risk in a prospective study. | Q40142103 | ||
| Association of Estrogen Metabolism with Breast Cancer Risk in Different Cohorts of Postmenopausal Women | Q40409564 | ||
| Insulin and colon cancer | Q40524787 | ||
| Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women | Q40747849 | ||
| Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers | Q42329676 | ||
| Cancer progression by reprogrammed BCAA metabolism in myeloid leukaemia | Q43748646 | ||
| Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies | Q43963634 | ||
| Serum insulin and C-peptide concentration and breast cancer: a meta-analysis | Q44072087 | ||
| Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women | Q44472863 | ||
| Physiological changes in circulating mannose levels in normal, glucose-intolerant, and diabetic subjects | Q44536722 | ||
| Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition | Q46831183 | ||
| Obesity and cancer: An update of the global impact. | Q51026568 | ||
| Plasma Amino Acid Levels and Insulin Secretion in Obesity | Q51685623 | ||
| Investigating sources of variability in metabolomic data in the EPIC study: the Principal Component Partial R-square (PC-PR2) method | Q57271306 | ||
| Reproducibility of Estradiol and Testosterone Levels in Postmenopausal Women Over 5 Years: Results From the Breakthrough Generations Study | Q59291360 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | metabolomics | Q12149006 |
| P304 | page(s) | 588-597 | |
| P577 | publication date | 2018-06-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk | |
| P478 | volume | 110 |
| Q90268902 | A Metabolomics Analysis of Adiposity and Advanced Prostate Cancer Risk in the Health Professionals Follow-Up Study |
| Q64923534 | Breast Cancer Metabolomics: From Analytical Platforms to Multivariate Data Analysis. A Review. |
| Q99562757 | Effect of Added Dietary Betaine and Soluble Fiber on Metabolites and Fecal Microbiome in Dogs with Early Renal Disease |
| Q91994195 | Metabolomics Analytics Workflow for Epidemiological Research: Perspectives from the Consortium of Metabolomics Studies (COMETS) |
| Q89449981 | Metabolomics and breast cancer: scaling up for robust results |
| Q90235925 | Prospective analysis of circulating metabolites and breast cancer in EPIC |
| Q90224413 | Steroidomics for the Prevention, Assessment, and Management of Cancers: A Systematic Review and Functional Analysis |
| Q92473267 | The Consortium of Metabolomics Studies (COMETS): Metabolomics in 47 Prospective Cohort Studies |
| Q60957114 | The Metabolome and Osteoarthritis: Possible Contributions to Symptoms and Pathology |
| Q50084039 | Using Metabolomics to Explore the Role of Postmenopausal Adiposity in Breast Cancer Risk. |
Search more.